Literature DB >> 11668578

Modeling of HLA class II susceptibility to Type I diabetes reveals an effect associated with DPB1.

A M Valdes1, J A Noble, E Génin, F Clerget-Darpoux, H A Erlich, G Thomson.   

Abstract

In this report, we present evidence that the HLA class II DPB1 locus (or a locus with alleles in linkage disequilibrium with DPB1) contributes to Type I diabetes (IDDM) susceptibility in addition to the contribution of the HLA DR and DQ loci. The marker association segregation chi-square (MASC) method, which fits both genotype frequency and affected sib-pair identity-by-descent (IBD) distributions, was applied to 257 sib pairs affected with IDDM. Fitting DR-DQ as the sole HLA susceptibility loci was strongly rejected. Next, we considered the DPB1 contribution to disease susceptibility. Published reports indicate a predisposing role for alleles DPB1*0301 and DPB1*0202, including our previous stratification analyses of association data on this sample. IDDM probands were stratified into those not carrying the alleles DPB1*0301 and DPB1*0202 (group DPB1-A), and those carrying at least one copy of either allele (group DPB1-B). Both groups of probands have almost identical frequencies of DR and DQ haplotypes but significantly different IBD distributions in the subset of families with probands who do not carry the highly predisposing DR3/DR4 genotype. In these data, DPB1 (or a locus in linkage disequilibrium), in addition to DR-DQ, is involved in IDDM susceptibility and affects IBD in the HLA region. Addition of DPB1 in a genetic model of IDDM gives a better fit to the data than consideration of DR-DQ alone. Our results are consistent with previous reports implicating DPB1 in IDDM susceptibility. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668578     DOI: 10.1002/gepi.1030

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  7 in total

Review 1.  Genetics of type 1 diabetes.

Authors:  Janelle A Noble; Henry A Erlich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era.

Authors:  Alan G Baxter; Margaret A Jordan
Journal:  Rev Diabet Stud       Date:  2012-12-28

3.  Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1.

Authors:  A M Valdes; G Thomson
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

4.  HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families.

Authors:  Henry Erlich; Ana Maria Valdes; Janelle Noble; Joyce A Carlson; Mike Varney; Pat Concannon; Josyf C Mychaleckyj; John A Todd; Persia Bonella; Anna Lisa Fear; Eva Lavant; Anthony Louey; Priscilla Moonsamy
Journal:  Diabetes       Date:  2008-02-05       Impact factor: 9.461

5.  HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.

Authors:  Janelle A Noble; Ana Maria Valdes; Michael D Varney; Joyce A Carlson; Priscilla Moonsamy; Anna Lisa Fear; Julie A Lane; Eva Lavant; Rebecca Rappner; Anthony Louey; Patrick Concannon; Josyf C Mychaleckyj; Henry A Erlich
Journal:  Diabetes       Date:  2010-08-26       Impact factor: 9.461

6.  Genetic variation within the HLA class III influences T1D susceptibility conferred by high-risk HLA haplotypes.

Authors:  A M Valdes; G Thomson; L F Barcellos
Journal:  Genes Immun       Date:  2010-01-07       Impact factor: 2.676

7.  Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A.

Authors:  J M M Howson; N M Walker; D Clayton; J A Todd
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.